Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

Title
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 384, Issue 13, Pages 1216-1226
Publisher
Massachusetts Medical Society
Online
2021-04-01
DOI
10.1056/nejmoa2021712

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started